Why the study?
Does streptokinase reduce the size and extent of thrombosis compared to anticoagulants in patients with deep vein thrombosis?
Does streptokinase reduce the size and extent of thrombosis compared to anticoagulants in patients with deep vein thrombosis?
Streptokinase can lyse fresh thrombus surrounded by flowing blood in patients with deep vein thrombosis, leading to a reduction in thrombus size compared to standard anticoagulants.
Answers are grounded in this paper and cite their sources.
May reduce DVT thrombus size; small observational data leave open need for RCTs before practice change.
Five patients with deep vein thrombosis were given streptokinase. Five others with similar phlebograms were given anticoagulants, and the results assessed by examining changes in the iliac, femoral, and calf segments of the phlebograms when repeated 7-10 days later. Those of the anticoagulant group were unchanged. Four of the five given streptokinase had a reduction in the size and extent of their thrombosis. Fresh thrombus surrounded by flowing blood was lysed. Thrombus completely blocking a vein was not lysed.The indications for the use of streptokinase in deep vein thrombosis are reviewed.
No takes yet. Share an insight, caveat, or question.
Browse et al. (1968) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: